Fierce Healthcare November 6, 2023
Two health secretaries from the Trump and Biden administrations agree that bringing down high drug costs is a critical priority to make healthcare more affordable for patients.
But they have far different views on the strategies to do it and the government’s role in the marketplace.
Former Department of Health and Human Services (HHS) Secretary Alex Azar, who served under the Trump administration, bashed the Biden administration’s program for negotiating lower Medicare drug prices with pharmaceutical companies, calling it “price fixing.”
“I’m quite nervous with the IRA that we’re going to see a dramatic reduction in the incentives of innovation. You won’t see investment in line extensions, you won’t have enough time to add new indications. You might see delayed...
Today's Sponsors
Today's Sponsor